+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07389408

Observing Treatment Decisions and Outcomes for Early Breast Cancer Patients Eligible for EndoPredict4 Testing A Prospective Multicenter Registry Study

Led by National and Kapodistrian University of Athens · Updated on 2026-02-05

2000

Participants Needed

13

Research Sites

561 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are observing and documenting treatment decisions, protocols, and clinical outcomes in patients with luminal ER-positiveHER2-negative early breast cancer who are eligible for EndoPredict4 testing. This prospective, multicenter, non-interventional registry includes patients who undergo EndoPredict testing and those who do not, aiming to understand real-world treatment patterns and long-term results. Participants have non-metastatic invasive breast cancer with tumor size T1 to T3 and 0 to 3 positive axillary lymph nodes. This observational study does not change patient treatment. Patients may enroll after surgery and before starting adjuvant endocrine therapy. The registry is conducted across multiple sites, mainly in Greece, with plans to enroll up to 2,000 participants over 3 years. Participants will be followed once yearly for up to 10 years after surgery. Researchers will collect data on clinical outcomes such as distant relapse-free survival, overall survival, and local relapse-free survival at 5 and 10 years. They will also evaluate how EndoPredict risk scores relate to treatment decisions and outcomes, alongside patient and disease characteristics influencing therapy choices.

CONDITIONS

Brief Title

A Prospective, Multicenter Registry to Observe the Treatment Patterns, Clinical Outcomes, and Decision-Making in Patients With Early Breast Cancer Eligible for EndoPredict® Testing

Research Team

M

Michalis Kontos

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here